The independent source for health policy research, polling, and news.
6,441 - 6,460 of 15,464 Results
The federal government is issuing bonuses and penalties to skilled nursing facilities based on how often their patients are readmitted to hospitals within a month of being discharged.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Enrollment is lagging this year as the Trump administration spends just $10 million on navigators to help individuals enroll in coverage, down from $63 million in 2016.
Do sales reps in the operating room lend helpful expertise or inflate already bloated costs? Depends on whom you ask.
The Trump administration offered states specific examples of how they could change the way they implement the Affordable Care Act. Critics say it could drive up premiums for many.
As consumers weigh health insurance options during open enrollment, location matters. Some parts of the country are seeing drops in premiums while others are experiencing another year of sticker shock.
In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”
Top House Republican also received more than $1 million from drugmakers since 2007.
The story of an Ohio mom who faced an outrageous bill for a new medicine for multiple sclerosis is the latest installment in the "Bill of the Month" series, an ongoing crowdsourced investigation by KHN and NPR.
About 276,000 more children are among the uninsured, a new report finds. Though the uptick is statistically small, it is striking because uninsured rates usually decrease during periods of economic growth.
Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.
A woman had twins in a hospital south of Boston, and for doctors aiming to reduce cesarean sections, the second baby's tricky arrival tested the limits of teamwork.
Hospital visits related to amphetamine use have spiked, with the biggest jumps in the West, new research shows. Experts say more attention needs be paid to the resurgence of methamphetamine.
It’s not clear why Asian-American college students have higher rates of compulsive gambling than their peers, but a nonprofit in the San Francisco Bay Area arms them with strategies to avoid getting hooked.
Premiums are lower as choices increase in many parts of the country. But the financial relief is not enough to erase the price hikes that have been imposed in recent years.
Smoke from the deadly and destructive Camp Fire has caused air quality readings to spike into “hazardous” and “unhealthy” levels for millions of people far outside of the burn zones. Is smoky air the new normal for California?
Plans offered through the Affordable Care Act marketplaces for 2019 are on sale now. Consumers should check them out soon, because in many states most sales end on Dec. 15.
Medical records often contain incorrect information that can lead to inappropriate medical treatment. Patients need to review them on a regular basis and correct any errors that creep in.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Joanne Kenen of Politico and Anna Edney of Bloomberg News discuss the latest on open enrollment for the Affordable Care Act and Medicare; new moves by the Food and Drug Administration to regulate tobacco and nicotine products; and whether House Democrats will pursue a “Medicare-for-all” bill in the next Congress. Plus, for extra credit, the panelists recommend their favorite health policy books for your holiday reading and gifting pleasure.
The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.
© 2026 KFF